CTKB Working Capital Ratio
Cytek Biosciences Inc · Working Capital Ratio
CTKB Working Capital Ratio
Latest reported65.69%period ending
CTKB Quarterly Working Capital Ratio (82.77% → 65.69%)
Quarterly working capital ratio
High-resolution chart · PNG
CTKB working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 65.6911% | |
| 66.4347% | |
| 68.0744% | |
| 63.2997% | |
| 62.7493% | |
| 64.8182% | |
| 65.8224% | |
| 66.6483% | |
| 68.5731% | |
| 67.6902% | |
| 67.9198% | |
| 70.004% | |
| 70.7032% | |
| 70.3627% | |
| 77.9593% | |
| 80.5866% | |
| 81.3527% | |
| 81.5654% | |
| 86.0237% | |
| 90.2034% | |
| 81.9758% | |
| 82.3908% | |
| 82.7743% |